Switch to:
GuruFocus has detected 1 Warning Sign with Cascadian Therapeutics Inc $CASC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Cascadian Therapeutics Inc (NAS:CASC)
Other Long-Term Liabilities
$0.14 Mil (As of Dec. 2016)

Cascadian Therapeutics Inc's other long-term liabilities for the quarter that ended in Dec. 2016 was $0.14 Mil.

Cascadian Therapeutics Inc's quarterly other long-term liabilities declined from Jun. 2016 ($0.26 Mil) to Sep. 2016 ($0.17 Mil) and declined from Sep. 2016 ($0.17 Mil) to Dec. 2016 ($0.14 Mil).

Cascadian Therapeutics Inc's annual other long-term liabilities increased from Dec. 2014 ($0.52 Mil) to Dec. 2015 ($1.14 Mil) but then declined from Dec. 2015 ($1.14 Mil) to Dec. 2016 ($0.14 Mil).


Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart’s balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all “Other Long-Term Liabilities”.

Related Terms

Total Liabilities

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Cascadian Therapeutics Inc Annual Data

Other Long-Term Liab. 12.260.0310.0913.0129.563.511.100.521.140.14

Cascadian Therapeutics Inc Quarterly Data

Other Long-Term Liab. 0.570.520.210.380.481.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)